Clinical Trial

Multi-component Remote Assessment in Adult Survivors Using a Connected Technology Platform for Healthcare Delivery

Withdrawn
View on ClinicalTrials.gov →
Why the trial stopped
After PI and vendor discussions, the decision was made not to proceed with the contract. The vendor's focus on large commercial efforts limits feasibility to support St. Jude clinical trial work.
Summary
This feasibility study evaluates a 12-week, multi-component remote assessment program for adult survivors of childhood cancer. The study aims to determine the participation and adherence rates to remote monitoring of cardiometabolic health using wearable devices, surveys, and laboratory testing facilitated by a third-party vendor. Primary Objective - To establish the feasibility of a multi-component remote assessment program for adult survivors. * The primary outcome for feasibility will be the participation rate (# eligible survivors approached who enroll) and completion rate (# of eligible survivors who enroll and remain on study through completion). * An additional outcome for feasibility will be adherence to the multicomponent remote assessment among participants. Secondary Objective * To estimate the proportion of participants who complete each individual study component (adherence to each individual component monitoring).
Protocol Amendment History 2 changes
critical Trial status changed: Not Yet Recruiting → Withdrawn 2026-04-07
notable Enrollment reduced: 100 -> 0 participants 2026-04-07
Trial Details
NCT Number NCT07222358
Lead Sponsor St. Jude Children's Research Hospital
Conditions Childhood Cancer
Start Date 2026-04
Primary Completion 2026-08 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2026-04-06